RASSF1 and neoplasm: We also observed heterogeneous methylation in 5/58 (8.6%) adjacent tissues of group B. According to the semi-quantitative MS-HRMA, in most positive cases RASSF1A promoter methylation was detected at a lower percentage in the adjacent morphologically tumor cell-free tissues, when compared to the paired primary tumors (Figure 2).